Moreover, a member of MYC transcription factor gene family, MYCN, is amplified in neuroblastoma cell lines and primary neuroblastomas and the progression of neuroblastoma disease tightly and adversely correlates with MYCN gene amplification, in that higher the amplification level poorer the clinical outcome [4]. Here, MYC is linked to neuroblastoma.